Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-16.86M.
ENTERPRISE VALUE (EV)
$-16.86M
Atossa Therapeutics, Inc.
Market Cap
$24.44M
Enterprise Value (EV)
$-16.86M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Atossa Therapeutics, Inc. (ATOS) | $24.44M | $-16.86M |
| Kyntra Bio, Inc. (KYNB)vs › | $24.65M | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | $27.21M |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | $13.69M |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | $27.74M |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | $16.91M |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | $23.57M |
| Cosmos Health Inc. (COSM)vs › | $18.82M | $32.99M |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | $18.63M |
| CervoMed Inc. (CRVO)vs › | $30.65M | $8.18M |
Market Cap
$24.44M
Total Debt
$0.00
Cash
$41.30M
Enterprise Value
$-16.86M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
